Global Brain has made an additional investment in Oobli, Inc., a startup developing sweet proteins

Global Brain has made an additional investment in Oobli, Inc. (Oobli), a startup developing sweet proteins in our modern diets, through its KIRIN HEALTH INNOVATION FUND and Norinchukin Innovation Fund L.P. (NCIF).

Oobli is a sweet protein technology platform company focused on replacing sugar in food and beverages. Sweet proteins have no glycemic impact or effect on the gut microbiome. Produced via fermentation, Oobli sweet proteins are both cost-effective as a sweetener replacement and climate friendly, saving massive amounts of land, water and carbon compared to farmed sugarcane. Oobli is the first and only company in the US* regulated to sell sweet proteins as a sweetener, with two FDA “no questions” letters, four proteins with self-affirmed FDA GRAS status and one protein with FDA FEMA GRAS status. In addition to selling its own protein-sweetened chocolates, Oobli partners with companies to help deliver great-tasting, affordable and healthier products. For more information, visit oobli.com.
* https://www.foodengineeringmag.com/articles/102710-oobli-receives-no-questions-letter-from-fda-for-protein-based-sweetener

As the “alternative sugar” market is rapidly expanding due to increasing human health and environmental protection needs, Global Brain sees huge potential in Oobli’s technological capabilities, speed of product development and successful team. Global Brain has decided to additionally invest in Oobli and will continuously leverage its resources to assist Oobli’s market penetration and international business expansion.

Note 1: Oobli changed its company name from Joywell Foods, Inc. in November 2022.
Note 2: In May 2022, Global Brain announced its initial investment in the company through its KIRIN HEALTH INNOVATION FUND and NCIF.
https://globalbrains.com/en/posts/invested-in-joywell